Literature DB >> 9588823

Resting distribution and stimulated translocation of protein kinase C isoforms alpha, epsilon and zeta in response to bradykinin and TNF in human endothelial cells.

D Ross1, W L Joyner.   

Abstract

Protein kinase C (PKC) has been linked to functional and morphological changes in endothelial cells involved in increased microvessel permeability. Bradykinin and TNF are potent inflammatory mediators which translocate PKC from the cytosol to the membrane of various cell types, including endothelial cells. The PKC isoforms alpha, epsilon and zeta have been demonstrated as the most prominent in human umbilical vein endothelial cells (HUVEC). We propose that bradykinin and TNF cause increased microvascular permeability via a PKC-dependent endothelial cell signalling pathway. HUVEC were incubated at 37 degrees C and 5% CO2 for 1 min, 15 min and 3 h with either bradykinin (1 microM) or TNF (100 U/ml). PMA incubation served as a positive control (100 nM, 15 min). Cytosolic and membrane-bound extracts were obtained by incubation in digitonin (0.5%) and Triton X100 (1%). PKC isoforms were assayed by Western blot and membrane fractions calculated. These experiments revealed that: HUVEC clearly displayed a non-uniform basal membrane fraction distribution of PKC isoforms, with zeta (35.4%) greater than epsilon (30.6%) and both much greater than alpha (8.6%); Bradykinin caused significant translocation of PKC alpha with 15 min and 3 h of treatment but not 1 min; TNF caused dramatic translocation of PKC alpha at 1 min treatment which subsided at 15 min and 3 h but remained significantly elevated; and PMA caused dramatic translocation of alpha and epsilon but not zeta. Treatments of bradykinin and TNF that translocated PKC also showed cytoskeletal rearrangement of rhodamine-phalloidin stained actin, causing it to become more prevalent near cell membranes and concentrated at focal points between cells. These results suggest that PKC alpha may contribute to long term low grade increases in microvessel permeability in response to bradykinin, and that PKC alpha could be involved in both transient and sustained microvessel permeability changes induced by TNF. Also, cytoskeletal actin organization appears to be a downstream pathway in the activation process, possibly leading to alteration in endothelial cell shape and contact points.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9588823     DOI: 10.3109/10623329709052596

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  8 in total

1.  Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.

Authors:  Zhen Li; Yun-hui Liu; Yi-xue Xue; Li-bo Liu; Ping Wang
Journal:  J Mol Neurosci       Date:  2012-04-25       Impact factor: 3.444

2.  Regulation of human organic anion transporter 3 by peptide hormone bradykinin.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  J Pharmacol Exp Ther       Date:  2010-03-18       Impact factor: 4.030

3.  Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae.

Authors:  H Ju; V J Venema; H Liang; M B Harris; R Zou; R C Venema
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 4.  IP3 receptor signaling and endothelial barrier function.

Authors:  Mitchell Y Sun; Melissa Geyer; Yulia A Komarova
Journal:  Cell Mol Life Sci       Date:  2017-08-12       Impact factor: 9.261

5.  The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition.

Authors:  Marika Massaro; Aida Habib; Laura Lubrano; Serena Del Turco; Guido Lazzerini; Todd Bourcier; Babette B Weksler; Raffaele De Caterina
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-03       Impact factor: 11.205

6.  Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption.

Authors:  Yao Yao; Stella E Tsirka
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

7.  Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase.

Authors:  V P Montecinos; C Aguayo; C Flores; A W Wyatt; J D Pearson; G E Mann; L Sobrevia
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

8.  In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways.

Authors:  M M Campos; G E Souza; J B Calixto
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.